Hospitalists working in behavioral health centers face unique challenges, including limited resources and complex patient ...

According to Lokant, if you have COVID and notice certain concerning symptoms, such as difficulty breathing, chest pain or ...

The interview with Dr Asad Khan on long Covid (Solidarity 747-748) highlights the contribution to the growth in mental ill-health of widespread long Covid, which affects hundreds of millions of ...

COVID-19 cases are rising in 26 states. Is the US in a summer wave? What to know about COVID trends and symptoms of the new ...

Bay Area researchers created a group of AI “scientists” that proposed a potential COVID treatment. They say the approach ...

Yonker is a co-inventor on a patent for zonulin antagonists to treat MIS-C, as are two other co-authors. Co-authors also ...

There have been lots of changes to COVID vaccine recommendations. Here is the current vaccine schedule for people 6 months to 65+ years old.

Janus kinase (JAK) inhibitors are associated with decreased mortality and fewer serious adverse events among adults hospitalized with COVID-19.

In a small trial, Mass General Brigham researchers have found that a drug designed to treat celiac disease supported a more rapid return to normal activities for patients following COVID.

Larazotide, a therapy known to treat celiac disease, shows promise as a safe treatment for multisystem inflammatory syndrome in children linked to COVID-19, enhancing recovery and symptom resolution.

Social risk factors significantly increase the likelihood of developing long COVID, highlighting the urgent need for ...